Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI

NCT03591991 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Reperfusion Injury, Myocardial

Interventions

DRUG: Empagliflozin
OTHER: placebo

Sponsor

Chinese PLA General Hospital